PHE update on vaccine supply issues, with BCG vaccine restrictions now lifted

  • Public Health England
  • Public Health England
  • 27 Oct 2018

  • curated by Priscilla Lynch
  • Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Public Health England (PHE) has issued an update on vaccine supply issues.

Ordering restrictions on the BCG vaccine have now been removed, so there is no longer a restriction on order quantities for the national BCG programme, said PHE. At times the shelf life of this product may be relatively short, therefore PHE advises against creating locally-held stockpiles.

In relation to the MMR vaccine, limited stocks are currently available for the private market but there are stocks available for the National Immunisation Programme.

There are currently two different vaccines available to order for the MMR programme, M-M-RvaxPro® and Priorix®. Orders for Priorix® continue to be capped at six packs per order per week for accounts in England and Wales. Controls are also in place for Scottish customers. This is needed to rebalance central supplies, said PHE.

M-M-RvaxPro® remains available to order without restriction.

If clinicians specifically require additional Priorix® stock, for example, because they serve communities that do not accept vaccines that contain porcine gelatine PHE has advised that they contact the ImmForm helpdesk for assistance.

There are also supply issues with the approved rabies vaccines and some hepatitis A and B vaccines, with limited stock of the pneumococcal polysaccharide vaccine (PPV) until December.